1
|
Xu S, Zhou F, Tao J, Song L, NG SC, Wang X, Chen L, Yi F, Ran Z, Zhou R, Xia B. Exome sequencing identifies DLG1 as a novel gene for potential susceptibility to Crohn's disease in a Chinese family study. PLoS One 2014; 9:e99807. [PMID: 24937328 PMCID: PMC4061034 DOI: 10.1371/journal.pone.0099807] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2014] [Accepted: 03/08/2014] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND Genetic variants make some contributions to inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). More than 100 susceptibility loci were identified in Western IBD studies, but susceptibility gene has not been found in Chinese IBD patients till now. Sequencing of individuals with an IBD family history is a powerful approach toward our understanding of the genetics and pathogenesis of IBD. The aim of this study, which focuses on a Han Chinese CD family, is to identify high-risk variants and potentially novel loci using whole exome sequencing technique. METHODS Exome sequence data from 4 individuals belonging to a same family were analyzed using bioinformatics methods to narrow down the variants associated with CD. The potential risk genes were further analyzed by genotyping and Sanger sequencing in family members, additional 401 healthy controls (HC), 278 sporadic CD patients, 123 UC cases, a pair of monozygotic CD twins and another Chinese CD family. RESULTS From the CD family in which the father and daughter were affected, we identified a novel single nucleotide variant (SNV) c.374T>C (p.I125T) in exon 4 of discs large homolog 1 (DLG1), a gene has been reported to play multiple roles in cell proliferation, T cell polarity and T cell receptor signaling. After genotyping among case and controls, a PLINK analysis showed the variant was of significance (P<0.05). 4 CD patients of the other Chinese family bore another non-synonymous variant c.833G>A (p.R278Q) in exon 9 of DLG1. CONCLUSIONS We have discovered novel genetic variants in the coding regions of DLG1 gene, the results support that DLG1 is a novel potential susceptibility gene for CD in Chinese patients.
Collapse
Affiliation(s)
- Shufang Xu
- Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People’s Republic of China
| | - Feng Zhou
- Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People’s Republic of China
- Hubei Clinical Center and Key Laboratory for Intestinal and Colorectal Diseases, and Hubei Key Laboratory of Immune Related Diseases, Wuhan, People’s Republic of China
| | - Jinsheng Tao
- BGI-Shenzhen, Bei Shan Industrial Zone, Yantian District, Shenzhen, People’s Republic of China
| | - Lu Song
- Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People’s Republic of China
| | - Siew Chien NG
- Institute of Digestive Disease, Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, People’s Republic of China
| | - Xiaobing Wang
- Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People’s Republic of China
| | - Liping Chen
- Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People’s Republic of China
- Hubei Clinical Center and Key Laboratory for Intestinal and Colorectal Diseases, and Hubei Key Laboratory of Immune Related Diseases, Wuhan, People’s Republic of China
| | - Fengming Yi
- Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People’s Republic of China
| | - Zhihua Ran
- Department of Gastroenterology, Renji Hospital, Shanghai Institute of Digestive Disease, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
| | - Rui Zhou
- Hubei Clinical Center and Key Laboratory for Intestinal and Colorectal Diseases, and Hubei Key Laboratory of Immune Related Diseases, Wuhan, People’s Republic of China
| | - Bing Xia
- Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People’s Republic of China
- Hubei Clinical Center and Key Laboratory for Intestinal and Colorectal Diseases, and Hubei Key Laboratory of Immune Related Diseases, Wuhan, People’s Republic of China
- * E-mail:
| |
Collapse
|